- Home
- MRUS vs INSP Comparison
MRUS vs INSP Comparison
Compare MRUS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- INSP
- Stock Information
- Founded
- MRUS 2003
- INSP 2007
- Country
- MRUS Netherlands
- INSP United States
- Employees
- MRUS N/A
- INSP N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- INSP Medical/Dental Instruments
- Sector
- MRUS Health Care
- INSP Health Care
- Exchange
- MRUS Nasdaq
- INSP Nasdaq
- Market Cap
- MRUS 4.1B
- INSP 4.6B
- IPO Year
- MRUS 2016
- INSP 2018
- Fundamental
- Price
- MRUS $52.90
- INSP $129.62
- Analyst Decision
- MRUS Strong Buy
- INSP Buy
- Analyst Count
- MRUS 12
- INSP 12
- Target Price
- MRUS $87.92
- INSP $213.75
- AVG Volume (30 Days)
- MRUS 1.2M
- INSP 556.8K
- Earning Date
- MRUS 07-31-2025
- INSP 08-05-2025
- Dividend Yield
- MRUS N/A
- INSP N/A
- EPS Growth
- MRUS N/A
- INSP N/A
- EPS
- MRUS N/A
- INSP 2.17
- Revenue
- MRUS $54,732,000.00
- INSP $840,111,000.00
- Revenue This Year
- MRUS $75.57
- INSP $20.61
- Revenue Next Year
- MRUS $31.84
- INSP $17.32
- P/E Ratio
- MRUS N/A
- INSP $61.12
- Revenue Growth
- MRUS 42.77
- INSP 27.11
- 52 Week Low
- MRUS $33.19
- INSP $123.00
- 52 Week High
- MRUS $62.98
- INSP $225.00
- Technical
- Relative Strength Index (RSI)
- MRUS 54.86
- INSP 37.79
- Support Level
- MRUS $52.53
- INSP $125.48
- Resistance Level
- MRUS $54.81
- INSP $133.65
- Average True Range (ATR)
- MRUS 1.70
- INSP 4.67
- MACD
- MRUS -0.55
- INSP 0.60
- Stochastic Oscillator
- MRUS 39.04
- INSP 32.07
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.